Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 8 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

5Total
Not Applicable (3)
P 1 (1)
P 2 (1)

Trial Status

Recruiting5
Not Yet Recruiting2
Unknown1

Clinical Trials (8)

Showing 8 of 8 trials
NCT07024719Not ApplicableRecruiting

4D Duke Microscope Integrated Optical Coherence Tomography in a Zeiss Artevo 800

NCT06755060Not ApplicableRecruitingPrimary

Ophthalmic AI-Assisted Medical Decision-Making

NCT06834906Not ApplicableRecruitingPrimary

Usability User Testing of the Easy-EyeFM AI Platform

NCT06755190RecruitingPrimary

Ophthalmic Multimodal AI-Assisted Medical Decision-Making

NCT06809751Phase 2Not Yet Recruiting

Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy

NCT06793514Phase 1Not Yet Recruiting

Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis

NCT03934957Recruiting

Hamburg City Health Study - a German Cohort Study

NCT00249392UnknownPrimary

Epidemiologic, Laboratory, and Clinical Characterization of Individuals With Ocular Diseases

Showing all 8 trials

Research Network

Activity Timeline